
First Volunteer Injected with Rapidly Developed Ebola Bundibugyo Vaccine in Oxford
Oxford University announced a volunteer received the first dose of a rapidly developed vaccine for the Bundibugyo strain of Ebola, responsible for over 1,000 deaths in DRC and Uganda. The ChAdOx1 BDBV vaccine, using AstraZeneca's Covid-19 vaccine technology, went from concept to clinic in eight weeks.





















